{
  "item7": [
    {
      "cluster": 1,
      "content": "ITEM 7:\nTABLE: TABLE: Years Ended (In Millions, Except Per Share Amounts) December 28, 2024 December 30, 2023 December 31, 2022; Amount % of NetRevenue Amount % of NetRevenue Amount % of NetRevenue; Net revenue $ 53,101 100.0 % $ 54,228 100.0 % $ 63,054 100.0 %; Cost of sales 35,756 67.3 % 32,517 60.0 % 36,188 57.4 %; Gross margin 17,345 32.7 % 21,711 40.0 % 26,866 42.6 %; Research and development 16,546 31.2 % 16,046 29.6 % 17,528 27.8 %; Marketing, general, and administrative 5,507 10.4 % 5,634 10.4 % 7,002 11.1 %; Restructuring and other charges 6,970 13.1 % (62) (0.1) % 2 — %; Operating income (loss) (11,678) (22.0) % 93 0.2 % 2,334 3.7 %; Gains (losses) on equity investments, net 242 0.5 % 40 0.1 % 4,268 6.8 %; Interest and other, net 226 0.4 % 629 1.2 % 1,166 1.8 %; Income (loss) before taxes (11,210) (21.1) % 762 1.4 % 7,768 12.3 %; Provision for (benefit from) taxes 8,023 15.1 % (913) (1.7) % (249) (0.4) %; Net income (loss) (19,233) (36.2) % 1,675 3.1 % 8,017 12.7 %; Less: net income (loss) attributable to non-controlling interests (477) (0.9) % (14) — % 3 — %; Net income (loss) attributable to Intel $ (18,756) (35.3) % $ 1,689 3.1 % $ 8,014 12.7 %; Earnings (loss) per share attributable to Intel—diluted $ (4.38) $ 0.40 $ 1.94.\nTITLE: $\nTITLE: 53,101\nTITLE: 100.0\nTITLE: %\nTITLE: 35,756\nTITLE: 67.3\nTITLE: %\nTITLE: 17,345\nTITLE: 32.7\nTITLE: %\nTITLE: 16,546\nTITLE: 31.2\nTITLE: %\nTITLE: 5,507\nTITLE: 10.4\nTITLE: %\nTITLE: 6,970\nTITLE: 13.1\nTITLE: %\nTITLE: (11,678)\nTITLE: (22.0)\nTITLE: %\nTITLE: 242\nTITLE: 0.5\nTITLE: %\nTITLE: 226\nTITLE: 0.4\nTITLE: %\nTITLE: (11,210)\nTITLE: (21.1)\nTITLE: %\nTITLE: 8,023\nTITLE: 15.1\nTITLE: %\nTITLE: (19,233)\nTITLE: (36.2)\nTITLE: %\nTITLE: (477)\nTITLE: (0.9)\nTITLE: %\nTITLE: $\nTITLE: (18,756)\nTITLE: (35.3)\nTITLE: %\nTITLE: $\nTITLE: (4.38)\nTITLE: Consolidated Revenue\nTITLE: Consolidated Revenue Walk $B\nTITLE: 1\nTITLE: 2024 vs. 2023\nTITLE: Consolidated Gross Margin\nTABLE: TABLE: .\nTITLE: Gross Margin $B\nTITLE: 2024 vs. 2023\nTITLE: Operating Expenses\nTABLE: TABLE: Research and Development $B Marketing, General, and Administrative $B.\nTITLE: Research and Development $B\nTITLE: Marketing, General, and Administrative $B\nTITLE: Research and Development\nTABLE: TABLE: .\nTITLE: 2024 vs. 2023\nTITLE: Marketing, General, and Administrative\nTABLE: TABLE: .\nTITLE: 2024 vs. 2023\nTITLE: Restructuring and Other Charges\nTABLE: TABLE: Years Ended (In Millions) Dec 28, 2024 Dec 30, 2023 Dec 31, 2022; Employee severance and benefit arrangements $ 2,481 $ 222 $ 1,038; Litigation charges and other 858 (329) (1,187); Asset impairment charges 3,631 45 151; Total restructuring and other charges $ 6,970 $ (62) $ 2.\nTITLE: $\nTITLE: 2,481\nTITLE: 858\nTITLE: 3,631\nTITLE: $\nTITLE: 6,970\nTITLE: Gains (Losses) on Equity Investments and Interest and Other, Net\nTABLE: TABLE: Years Ended (In Millions) Dec 28, 2024 Dec 30, 2023 Dec 31, 2022; Unrealized gains (losses) on marketable equity investments $ (218) $ (99) $ (829); Unrealized gains (losses) on non-marketable equity investments1 92 17 299; Impairment charges (347) (214) (190); Unrealized gains (losses) on equity investments, net (473) (296) (720); Realized gains (losses) on sales of equity investments, net 715 336 4,988; Gains (losses) on equity investments, net 242 40 4,268; Interest and other, net $ 226 $ 629 $ 1,166.\nTITLE: $\nTITLE: (218)\nTITLE: $\nTITLE: 226\nTITLE: Gains (Losses) on Equity Investments, Net\nTITLE: Interest and Other, Net\nTITLE: Provision for (Benefit from) Taxes\nTABLE: TABLE: Years Ended ($ In Millions) Dec 28, 2024 Dec 30, 2023 Dec 31, 2022; Income (loss) before taxes $ (11,210) $ 762 $ 7,768; Provision for (benefit from) taxes $ 8,023 $ (913) $ (249); Effective tax rate 71.6 % (119.8) % (3.2) %.\nTITLE: $\nTITLE: (11,210)\nTITLE: $\nTITLE: 8,023\nTITLE: 71.6\nTITLE: %\nTITLE: Liquidity and Capital Resources\nTABLE: TABLE: (In Millions) Dec 28, 2024 Dec 30, 2023; Cash and cash equivalents $ 8,249 $ 7,079; Short-term investments 13,813 17,955; Total cash and short-term investments $ 22,062 $ 25,034; Total debt $ 50,011 $ 49,266.\nTITLE: $\nTITLE: 8,249\nTITLE: 13,813\nTITLE: $\nTITLE: 22,062\nTITLE: $\nTITLE: 50,011\nTABLE: TABLE: Years Ended (In Millions) Dec 28, 2024 Dec 30, 2023 Dec 31, 2022; Net cash provided by (used for) operating activities $ 8,288 $ 11,471 $ 15,433; Net cash provided by (used for) investing activities (18,256) (24,041) (10,231); Net cash provided by (used for) financing activities 11,138 8,505 1,115; Net increase (decrease) in cash and cash equivalents $ 1,170 $ (4,065) $ 6,317.\nTITLE: $\nTITLE: 8,288\nTITLE: (18,256)\nTITLE: 11,138\nTITLE: $\nTITLE: 1,170\nTITLE: Operating Activities\nTITLE: Investing Activities\nTITLE: Financing Activities\nTITLE: Critical Accounting Estimates\nTITLE: ▪\nTITLE: Inventories\nTITLE: ▪\nTITLE: Long-lived assets\nTITLE: ▪\nTITLE: Loss contingencies\nTITLE: Non-GAAP Financial Measures\nTABLE: TABLE: Years Ended (In Millions) Dec 28, 2024 Dec 30, 2023 Dec 31, 2022 Dec 25, 2021 Dec 26, 2020; Net cash provided by (used for) operating activities $ 8,288 $ 11,471 $ 15,433 $ 29,456 $ 35,864; Net purchase of property, plant, and equipment (10,515) (23,228) (23,724) (18,567) (14,086); Payments on finance leases (1) (96) (345) — —; Sale of equity investment — — 4,561 — —; Adjusted free cash flow $ (2,228) $ (11,853) $ (4,075) $ 10,889 $ 21,778; Net cash provided by (used for) investing activities $ (18,256) $ (24,041) $ (10,231) $ (24,283) $ (21,351); Net cash provided by (used for) financing activities $ 11,138 $ 8,505 $ 1,115 $ (6,211) $ (12,842).\nTITLE: $\nTITLE: 8,288\nTITLE: (10,515)\nTITLE: (1)\nTITLE: —\nTITLE: $\nTITLE: (2,228)\nTITLE: $\nTITLE: (18,256)\nTITLE: $\nTITLE: 11,138\n"
    }
  ],
  "item8": []
}